MAO inhibitors (MAOIs): all 125 studies that test it
Page 2 of 2. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of CigarettesCompletedNCT00622752Phase 2
- MOTION, Safinamide in Early IPD, as add-on to Dopamine AgonistCompletedNCT00605683Phase 3
- Benzamide Derivates as Treatment of Clozapine-induced HypersalivationCompletedNCT00534573Phase 3
- Evaluation of Adhesion and Dermal Tolerability of EMSAMCompletedNCT00531596Phase 4
- Efficacy of Selegiline in Negative Symptoms of SchizophreniaCompletedNCT00456976Early Phase 1
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseCompletedNCT00399477Phase 4
- Testing a Full Substitution Therapy Approach As Treatment of Tobacco DependenceTerminatedNCT00390923Not applicable
- Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory DepressionTerminatedNCT00296686Phase 4
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
- Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1CompletedNCT00218517Phase 2
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.CompletedNCT00203177Phase 3
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease PatientsCompletedNCT00203164Phase 3
- Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's DiseaseCompletedNCT00203138Phase 3
- A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.CompletedNCT00203125Phase 3
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaCompletedNCT00203060Phase 3
- Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor FluctuationsCompletedNCT00203034Phase 3
- Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00104273Phase 2
- Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Status unknownNCT00033072Phase 1
- Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1CompletedNCT00032929Phase 3
- A Study of Decreased Mental Function Associated With HIVCompletedNCT00027040Not applicable
- Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV PatientsCompletedNCT00013585Phase 2
- Infusion Laboratory: Protocol 1 - Selegeline - 2CompletedNCT00000337Phase 1
- Selegiline in Outpatient Treatment for Cocaine Dependence - 1CompletedNCT00000336Phase 2
- Pharmacological Modulation of Cocaine Effects - 1CompletedNCT00000201Phase 2
- Selegiline in Treatment of Cocaine Dependence - 2CompletedNCT00000188Phase 2